Abbott 'Goes Red' to Educate Bay Area Women About Hea... (cise a regular part of my life and has h...)

Abbott 'Goes Red' to Educate Bay Area Women About Heart Disease

Date:2/1/2008

cise a regular part of my life and has helped repair the damage to my

heart. Through this campaign, I hope other women hear my story and take

steps to understand their risk for heart disease."

Michelle Smietana, of Abbott, 33-year-old heart attack victim

According to AHA, Michelle is not alone. Heart attacks strike 9,000 women younger than 45 each year.

To increase the awareness of this and other little known facts about heart disease, Dr. Sandra Burke, a scientist in the Santa Clara-based vascular division of Abbott, is dedicating her career and her free time to fighting heart disease.

"Abbott and AHA urge women to talk to their doctors about their risk of

heart disease and to start taking action to lead healthier lives."

Dr. Sandra Burke

Director, cardiovascular biology research, Abbott Vascular

In addition to raising awareness through campaigns like "Go Red," Abbott is committed to developing new drugs and medical devices to treat heart disease and related conditions. With diagnostic tests, pharmaceutical products, nutritional products and vascular stents to diagnose and treat heart disease, Abbott has one of the world's leading heart disease and vascular care businesses.

Abbott's CEO, Miles White, sent an e-mail to the company's 35,000 U.S. employees earlier today echoing this commitment.

"Abbott is in the fight against heart disease for the long haul and

through all the means at our disposal: with our diagnostic tests to

identify cardiovascular conditions, our pharmaceutical treatments to

improve patients' cardiovascular health, our nutritional products that

help to improve cardiovascular status, and our stents that relieve acute

vascular conditions by reopening blocked arteries. It's only natural that

we lend our philanthropic support and the skills and commitment of our

people, as well." <
'/>"/>

0

GOOD

Page: 1 2 3
Related medicine news :

1. Abbott to Present at Merrill Lynch Healthcare Conference
2. Abbotts Kaletra(R) and Aluvia(R) (lopinavir/ritonavir) New Lower-Strength Tablet for Pediatric Use Receives Positive Opinion from EMEA
3. Abbott Hosts Conference Call for Fourth-Quarter and Full-Year 2007 Earnings
4. Cookie Johnson and Abbott Bring I Stand With Magic: Campaign to End Black AIDS to Los Angeles to Educate African-American Women on HIV/AIDS
5. Ugandan Children Are Among the First to Receive Abbotts Lower-Strength Aluvia (lopinavir/ritonavir) Tablet
6. The Magic Johnson Foundation and Abbott Expand Focus of Campaign to End Black AIDS to African-American Women in 2008
7. FDA Advisory Committee Recommends Approval of Abbotts XIENCE(TM) V Drug Eluting Stent System
8. Abbotts Environmental Protection Initiatives Again Recognized by the State of Illinois
9. Abbott Employees Give Back to Local Communities This Holiday Season
10. AUDIO from Medialink and Abbott Labs: Easing Holiday Stress for Families of Those With Diabetes
11. Abbott Receives U.S. Food and Drug Administration Approval for New Lower-Strength Kaletra(R) (lopinavir/ritonavir) Tablet for Pediatric HIV Patients

Post Your Comments:

Abbott 'Goes Red' to Educate Bay Area Women About Hea...(cise a regular part of my life and has h...),Health